Back to Home

TEAM

🔒 LOCKED

Atlassian Corporation

Current Price
$76.17
Confidence Score
85%
🔒 LOCKED
Intrinsic Value
$120.50
🔒 LOCKED
Cache Age
1086 hours ago

🔒 Unlock Full Analysis

Sign in and use 1 credit to see AI verdict, intrinsic value, SWOT analysis, and all premium insights.

AI Executive Summary

Atlassian exhibits strong growth potential but requires improved profitability to justify its valuation; a cautious buy.

The Business DNA

Headline: The Business DNA. Atlassian Corporation (TEAM) is a leading provider of collaboration and productivity software designed to connect teams and unlock their potential. Founded in 2002, the company has grown from a small startup to a global enterprise serving a diverse range of industries. Atlassian's core product suite includes Jira, Confluence, Trello, Bitbucket, and Jira Service Management. Jira is a project management tool used for planning, tracking, and managing work across various teams. Confluence is a collaborative workspace that allows teams to create, organize, and share knowledge. Trello is a visual project management tool known for its simplicity and flexibility. Bitbucket is a Git-based code repository management tool for software development teams. Jira Service Management is an IT service management solution designed to streamline IT operations and improve customer service. Atlassian's business model is primarily based on a subscription model, providing recurring revenue and predictable growth. The company focuses on a 'land and expand' strategy, acquiring customers through freemium offerings and then upselling them to higher-tier subscriptions with more features and support. This approach has proven effective in attracting a broad customer base, ranging from small startups to large enterprises. Atlassian's competitive advantage lies in its comprehensive product suite, strong brand recognition, and a large and active user community. The company's products are deeply integrated into the workflows of many organizations, creating high switching costs and customer loyalty. Furthermore, Atlassian's focus on innovation and continuous product improvement helps it stay ahead of competitors. The company invests heavily in research and development to enhance its existing products and develop new solutions to meet the evolving needs of its customers. Atlassian's international revenue trends are a critical factor in assessing the company's financial stability and growth prospects. The company derives a significant portion of its revenue from international markets, making it essential to understand the dynamics of these markets and the potential risks and opportunities they present. Factors such as currency fluctuations, geopolitical risks, and varying levels of technology adoption can impact Atlassian's international revenue. The company's ability to navigate these challenges and capitalize on growth opportunities in international markets will be crucial to its long-term success. Atlassian's AI offerings, such as Rovo, are increasingly important in driving future growth. The integration of AI into its products enhances their functionality and provides users with valuable insights and automation capabilities. This focus on AI innovation positions Atlassian to capitalize on the growing demand for AI-powered solutions in the collaboration and productivity software market.

Financial Health

Valuation Analysis

Headline: Valuation Check. Atlassian's valuation is complex, given its current lack of profitability juxtaposed with high growth expectations. The current price of $92.89 is significantly below its 52-week high of $326, reflecting a substantial correction in the market's perception of the stock. However, it's trading just above its 52-week low of $88.51, suggesting a potential bottom. The analyst target mean price of $183.98 indicates a significant upside potential if the company can execute its growth strategy and improve profitability. The forward P/E ratio of 16.86 suggests that the market anticipates a turnaround in Atlassian's earnings. This valuation is predicated on the assumption that Atlassian will be able to leverage its strong revenue growth and improve its cost structure. However, the absence of a PEG ratio makes it difficult to assess whether the stock is undervalued or overvalued relative to its growth rate. The price-to-sales ratio of 4.245 is relatively high, indicating that investors are paying a premium for Atlassian's revenue. This could be justified if the company can sustain its high growth rate and improve its profit margins. However, if growth slows down or profitability remains elusive, the stock could be vulnerable to a correction. The price-to-book ratio of 15.502 is also high, suggesting that Atlassian's assets may be overvalued. This could be a concern if the company's financial performance does not improve. A discounted cash flow (DCF) analysis would be necessary to determine the intrinsic value of Atlassian's stock. This analysis would need to take into account the company's revenue growth rate, profit margins, and discount rate. Given the company's current lack of profitability, the DCF analysis would need to assume a significant improvement in profit margins over the next few years. The sensitivity of the DCF analysis to changes in these assumptions should also be considered. Relative valuation metrics, such as comparing Atlassian's P/E ratio and price-to-sales ratio to those of its competitors, can also provide insights into the company's valuation. However, it's important to note that Atlassian's business model and growth prospects may differ from those of its competitors, making direct comparisons challenging. Overall, Atlassian's valuation is highly dependent on its ability to execute its growth strategy and improve its profitability. Investors should carefully consider the risks and uncertainties associated with the company's financial performance before making an investment decision.

Risks & Catalysts

Final Verdict: 🔒 LOCKED

Confidence Score
0%
Intrinsic Value
$🔒 LOCKED

Want More AI-Powered Analysis?

Get unlimited stock analyses, portfolio tracking, and real-time alerts

Related Stock Analyses

This analysis is generated by AI and should not be considered financial advice. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.

Last updated: 3/16/2026